HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moore, A. Articles by Weissleder, R. Search for Related Content PubMed PubMed Citation Articles by Moore, A. Articles by Weissleder, R. Social Bookmarking                What's this?

Noninvasive In Vivo Measurement of ß-Cell Mass in Mouse Model of Diabetes

¹ Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
² Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts

Pancreatic ß-cell mass (BCM) is a major determinant of the quantity of insulin that can be secreted. BCM is markedly reduced in type 1 diabetes because of selective autoimmune destruction of ß-cells. Accurate assessment of BCM in human diabetes is limited to autopsy studies, which usually suffer from inadequate clinical information; thus, the development of noninvasive means of BCM measurement could be important in intervention therapy. The goal of this study was to develop such noninvasive methods for measuring BCM featuring target-specific imaging probes and to investigate whether this technique is feasible, accurate, and predictive of BCM in normal and diabetic states. Using a ß-cell–specific monoclonal antibody IC2, modified with a radioisotope chelator for nuclear imaging, we showed that highly specific binding and accumulation to ß-cells occurs after intravenous administration of the probe, with virtually no binding to exocrine pancreas or stromal tissues. Furthermore, we observed a direct correlation between accumulation of the probe with BCM in diabetic and normal animals. Nuclear imaging of the animals that received an injection of the radioactive probe showed major difference in signal intensity between normal and diabetic pancreases. The results from this study set the route for further development of imaging probes for measuring BCM that would aid in diagnosis and treatment of diabetic patients in the clinic.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				M. O. Larsen, B. Rolin, J. Sturis, M. Wilken, R. D. Carr, N. Porksen, and C. F. Gotfredsen Measurements of insulin responses as predictive markers of pancreatic beta-cell mass in normal and beta-cell-reduced lean and obese Gottingen minipigs in vivo Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E670 - E677. [Abstract] [Full Text] [PDF]

				K. N. Samli, M. J. McGuire, C. B. Newgard, S. A. Johnston, and K. C. Brown Peptide-Mediated Targeting of the Islets of Langerhans Diabetes, July 1, 2005; 54(7): 2103 - 2108. [Abstract] [Full Text] [PDF]

				M. O. Larsen, B. Rolin, M. Wilken, R. D. Carr, and C. F. Gotfredsen Measurements of Insulin Secretory Capacity and Glucose Tolerance to Predict Pancreatic {beta}-Cell Mass In Vivo in the Nicotinamide/Streptozotocin Gottingen Minipig, a Model of Moderate Insulin Deficiency and Diabetes Diabetes, January 1, 2003; 52(1): 118 - 123. [Abstract] [Full Text] [PDF]

				E. A. Ryan, J. R.T. Lakey, B. W. Paty, S. Imes, G. S. Korbutt, N. M. Kneteman, D. Bigam, R. V. Rajotte, and A.M. J. Shapiro Successful Islet Transplantation: Continued Insulin Reserve Provides Long-Term Glycemic Control Diabetes, July 1, 2002; 51(7): 2148 - 2157. [Abstract] [Full Text] [PDF]